Raymond James & Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $493K | Sell |
52,456
-7,463
| -12% | -$70.1K | ﹤0.01% | 3106 |
|
2024
Q2 | $481K | Sell |
59,919
-7,371
| -11% | -$59.1K | ﹤0.01% | 3079 |
|
2024
Q1 | $997K | Buy |
67,290
+50,380
| +298% | +$747K | ﹤0.01% | 2581 |
|
2023
Q4 | $137K | Buy |
16,910
+3,868
| +30% | +$31.4K | ﹤0.01% | 3566 |
|
2023
Q3 | $59.3K | Buy |
13,042
+125
| +1% | +$569 | ﹤0.01% | 3631 |
|
2023
Q2 | $90.9K | Buy |
12,917
+2,700
| +26% | +$19K | ﹤0.01% | 3600 |
|
2023
Q1 | $62.4K | Buy |
+10,217
| New | +$62.4K | ﹤0.01% | 3666 |
|
2022
Q4 | – | Sell |
-19,863
| Closed | -$190K | – | 3838 |
|
2022
Q3 | $190K | Buy |
19,863
+50
| +0.3% | +$478 | ﹤0.01% | 3440 |
|
2022
Q2 | $219K | Buy |
19,813
+4,427
| +29% | +$48.9K | ﹤0.01% | 3423 |
|
2022
Q1 | $256K | Buy |
15,386
+5,350
| +53% | +$89K | ﹤0.01% | 3489 |
|
2021
Q4 | $192K | Buy |
10,036
+1,797
| +22% | +$34.4K | ﹤0.01% | 3682 |
|
2021
Q3 | $203K | Sell |
8,239
-8,726
| -51% | -$215K | ﹤0.01% | 3632 |
|
2021
Q2 | $441K | Sell |
16,965
-2,480
| -13% | -$64.5K | ﹤0.01% | 3166 |
|
2021
Q1 | $616K | Sell |
19,445
-1,853
| -9% | -$58.7K | ﹤0.01% | 2856 |
|
2020
Q4 | $988K | Sell |
21,298
-26,151
| -55% | -$1.21M | ﹤0.01% | 2349 |
|
2020
Q3 | $1.56M | Buy |
47,449
+6,521
| +16% | +$215K | ﹤0.01% | 1910 |
|
2020
Q2 | $1.12M | Buy |
40,928
+50
| +0.1% | +$1.37K | ﹤0.01% | 2077 |
|
2020
Q1 | $1.22M | Buy |
40,878
+27,354
| +202% | +$819K | ﹤0.01% | 1851 |
|
2019
Q4 | $374K | Sell |
13,524
-988
| -7% | -$27.3K | ﹤0.01% | 2929 |
|
2019
Q3 | $264K | Sell |
14,512
-4,281
| -23% | -$77.9K | ﹤0.01% | 3066 |
|
2019
Q2 | $461K | Buy |
+18,793
| New | +$461K | ﹤0.01% | 2728 |
|
2018
Q3 | – | Sell |
-52,856
| Closed | -$677K | – | 3530 |
|
2018
Q2 | $677K | Buy |
52,856
+883
| +2% | +$11.3K | ﹤0.01% | 2477 |
|
2018
Q1 | $878K | Buy |
+51,973
| New | +$878K | ﹤0.01% | 2224 |
|
2016
Q2 | – | Sell |
-13,700
| Closed | -$70K | – | 2936 |
|
2016
Q1 | $70K | Buy |
+13,700
| New | +$70K | ﹤0.01% | 2732 |
|